Vaccine programs

CALIXAR conducts intensive internal research efforts on specific membrane antigens.

The production of the viral antigens listed below is currently being optimized in our labs and some of them are already available in our catalogue for research purposes only.

For all developments related vaccine discovery, an exclusive or non-exclusive license must be set up.





Human immunodeficiency virus infection has caused an estimated 36 million deaths worldwide and approximately 35.3 million people are living with HIV globally.

Good candidate for vaccine and antibody discovery.


Leptospira Membrane Proteome

Leptospira is a bacteria that is responsible for Leptospirosis or field fever or rat catcher’s yellows transmitted by both wild and domestic animals.

Very important target for vaccine development.


Influenza antigens

Annual epidemics of influenza are thought to result in between three and five million cases of severe illness and between 250,000 and 500,000 deaths every year around the world.

Crucial to improve vaccine efficacy.